Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

ABPI London offices

UK pharma rebate payment doubles in one year

First quarter repayment £138m higher than this time last year

- PMLiVE

Rivals look to put pressure on Sanofi’s Lantus

Novo Nordisk and Lilly claim clinical benefitsover top-selling diabetes drug

- PMLiVE

Senior healthcare marketer joins Cello Health Consulting

Robert Stringer brings 20 years’ marketing experience to the role

Sanofi reception

Sanofi and Amgen poised for cholesterol drug sales

Praluent to be assessed by FDA advisory committee later this week

- PMLiVE

Takeda files block on generic diet pill launch

Contrave is succumbing to patent attacks just months after being approved

Shire Basingstoke

Shire rumoured to be pursuing Actelion

Allegedly made a £12.4bn takeover bid for the Swiss biopharma

Redirecting your patient strategy

Pharma’s efforts to update its approach to patients often start at the top

- PMLiVE

Novo brings Xultophy to third European market

Launches diabetes combination of Tresiba-Victoza in the UK

- PMLiVE

FDA panel backs Sprout Pharma’s ‘female Viagra’

Could be approved for HSDD in pre-menopausal women

EU flag

Pharma says EU R&D budget cut ‘misguided’

EU lobby group criticises science funding cuts

Gilead Sciences

Humira remains top pharma product, but Sovaldi closes in

AbbVie’s blockbuster may be bumped to second place this year

- PMLiVE

Ardelyx buys back drug from AZ to ‘accelerate development’

The two firms have been working on the NHE3 inhibitor tenapanor since 2012

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links